Multiple myeloma (first line) - bortezomib and thalidomide: appeal
An appeal has been lodged for this appraisal. Below are the papers related to this appeal.
For more information on the Technology Appraisal Appeal Process, go to the appeal hearings homepage.
Multiple myeloma (first line) - bortezomib and thalidomide: appeal decision
Multiple myeloma (first line) - bortezomib and thalidomide: background information
Multiple myeloma (first line) - bortezomib and thalidomide: notice of appeal
Multiple myeloma (first line) - bortezomib and thalidomide: appeal registration
Multiple myeloma (first line) - bortezomib and thalidomide: appeal announcement
This page was last updated: 12 January 2011